Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Orexo on private placement
Mandate

Vinge advised Orexo on private placement

September 08, 2014

Orexo AB (publ) (NASDAQ OMX Stockholm) has completed a private placement of Orexo shares to qualified investors, resulting in total cash proceeds of approximately SEK 346.5 million before transaction costs.

Vinge acted as legal adviser to Orexo. The Vinge team included Erik Sjöman (partner, capital markets and public M&A) and associates Christian Lindhé, Rikard Lindahl and Madelene Eriksson.

 

 

Related

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

 Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026

Vinge advises Revivo Group on acquisition of Haapanen

 Revivo Group, a comprehensive provider of qualified surface treatment services, has acquired Haapanen, a well-established Finnish specialist company.
January 14, 2026

Vinge advises Morrow Bank in connection with cross-border merger and list change from Oslo Børs to Nasdaq Stockholm

 Vinge has advised Morrow Bank in connection with its reverse cross-border merger, whereby Morrow Bank AB is taking over Morrow Bank ASA. The Norwegian bank was previously listed on the Oslo Stock Exchange which was today transferred to Nasdaq Stockholm. Vinge has previously assisted Morrow Bank in obtaining a Swedish banking licence.
January 12, 2026